Citations 2
Impact of primary (1º) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance).
Niedzwiecki, Donna , Innocenti, Federico , Fruth, Briant, Greene, Claire, O’Neil, Bert H. , Atkins, James N., Horvath, Laura E., Polite, Blasé N. , Goldberg, Richard M. , Höchster, Howard S. , Blanke, Charles D. , Schilsky, Richard L. , Lenz, Heinz‐Josef , Niedzwiecki, Donna , Venook, Alan P. , Shaw, James Edward , Meyerhardt, Jeffrey A. , O’Reilly, Eileen M. , Mayer, Robert J. , Bertagnolli, Monica M.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3504-3504
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer
Niedzwiecki, Donna , Lenz, Heinz‐Josef , Innocenti, Federico , Fruth, Briant, Meyerhardt, Jeffrey A. , Greene, Claire, O’Neil, Bert H. , Atkins, James N., Berry, Scott , Polite, Blasé N. , O’Reilly, Eileen M. , Goldberg, Richard M. , Höchster, Howard S. , Schilsky, Richard L. , Benson, Al B. , Mulkerin, Daniel , Blanke, Charles D. , Venook, Alan P. , Schrag, Deborah , Bertagnolli, Monica M. , El-Khoueiry, Anthony B. , Watson, Peter J. , Mayer, Robert J. , Meyerhardt, Jeffrey A , O'Reilly, Eileen M , Niedzwiecki, Donna
JAMA | June 20, 2017 | Volume: 317 | Issue: 23 | Pages: 2392